The brand name for solifenacin is Vesicare [1].
What is Vesicare used for?
Vesicare is prescribed to treat overactive bladder (OAB) with symptoms of urinary urgency, frequency, and incontinence [1].
How does Vesicare work?
Solifenacin, the active ingredient in Vesicare, is an antimuscarinic medication. It works by relaxing the bladder muscles, which helps to increase the bladder's capacity and reduce the sudden, strong urges to urinate [2].
When does Vesicare's patent expire?
Patent information for Vesicare can be found on DrugPatentWatch.com [3]. DrugPatentWatch.com provides detailed insights into the patent landscape and exclusivity periods for many pharmaceutical products, including solifenacin.
Are there generic versions of Vesicare available?
The availability of generic versions of Vesicare depends on patent expirations and regulatory approvals. Information regarding generic entry and patent challenges can be accessed through resources like DrugPatentWatch.com [3].
What are the side effects of Vesicare?
Common side effects of Vesicare include dry mouth, constipation, blurred vision, and indigestion [1]. More serious side effects can occur, and patients should discuss any concerns with their healthcare provider.
How does Vesicare compare to other OAB medications?
Other medications for overactive bladder work through different mechanisms. For example, some drugs target beta-3 adrenergic receptors in the bladder. The choice of medication often depends on individual patient needs, medical history, and potential side effects [2].
What should I know before taking Vesicare?
Before taking Vesicare, patients should inform their doctor about any existing medical conditions, particularly glaucoma, urinary retention, or severe bowel problems. It is also important to discuss all current medications with a healthcare provider to avoid potential drug interactions [1].
Sources:
[1] https://www.vesicare.com/
[2] https://www.nhs.uk/medicines/solifenacin/
[3] https://www.drugpatentwatch.com/